103,000 people are hospitalized every year because of side effects from common painkillers and an estimated 16,500 people die.
Boise, ID (PRWEB) December 5, 2006
With about 40 million Americans suffering from some form of chronic pain or severe pain, its makes sense that many seek relief with painkilling drugs or analgesics. However, while many experience temporary relief from that pain by taking painkillers, most don't realize that they are increasing the risk of gastrointestinal (GI) problems. In fact, according to the American Gastroenterological Association, "103,000 people are hospitalized every year because of side effects from common painkillers and an estimated 16,500 people die." Due to the rising concern of how ingested painkillers can affect the stomach and intestines, DRCT, LLC responds by introducing an all new liquid analgesic spray, called AspirSpray (http://www.aspirspray.com), to the American market. AspirSpray is a topical, alternative pain relief for muscle and joint pains, such as arthritis, without time delay and gastrointestinal discomfort of ingested pain relievers.
"The same chemicals that amplify pain, which some pain medicines block, also help maintain the protective lining of the stomach and intestines," states Chris Guill, Co-Owner of DRCT, LLC. "AspirSpray is unique in comparison to digested painkillers, because it does not interact with the chemicals that help protect the lining of the stomach and intestines. When a digested painkiller stops these chemicals from working, the digestive tract becomes more vulnerable to damage from gastric acids."
Unlike other topical creams and ointments, which use ingredients that give a heating or cooling sensation to the surface of the pain rather than actually relieving the pain, AspirSpray has an active ingredient called Trolamine Salicylate which is designed to relieve the pain. Trolamine Salicylate, is a combination of analgesic power with extract from the Aloe Vera plant in a hydro-alcoholic formulation. This produces a topical pain reliever which goes directly to the source of the pain without navigating the body's typical distribution system via the stomach, then the blood supply. AspirSpray is also designed to increase the levels of Salicylate in tendons, cartilage, ligaments and joint cavities. Increasing the levels of Salicylate prolongs the duration and degree of pain relieving action. AspirSpray is an FDA Registered and patented product.
AspirSpray relieves pain by the same mechanism as inserted nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen and naprosyn, but because it is a topical spray, it doesn't have the same risks that NSAIDs have after long-term use. In fact, studies show that people who use NSAIDs are about three times more likely to have gastrointestinal bleeding and induced ulcers.
"The analgesic liquid of AspirSpray works like aspirin and ibuprofen from a physiological standpoint," states Guill. "But instead of getting in the intestinal tract and blood stream, effecting the stomach and intestine lining, AspirSpray's formula penetrates the skin at the source of the pain, resulting in quick, effective pain relief."
For more information regarding AspirSpray, please visit http://www.aspirspray.com or phone 800-933-3640.
About AspirSpray--Designed to topically relieve pain from sore muscles, shin splints, arthritis, tendonitis, leg cramps, carpal tunnel, and back, neck, or joint pains, Aspirspray is privately distributed by DRCT, LLC. For additional information about Aspirspray or DRCT, please visit http://www.aspirspray.com or phone 800-933-3640.